vs

Side-by-side financial comparison of CASS INFORMATION SYSTEMS INC (CASS) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

OptimizeRx Corp is the larger business by last-quarter revenue ($32.2M vs $26.2M, roughly 1.2× CASS INFORMATION SYSTEMS INC). CASS INFORMATION SYSTEMS INC runs the higher net margin — 31.3% vs 15.6%, a 15.7% gap on every dollar of revenue. On growth, OptimizeRx Corp posted the faster year-over-year revenue change (-0.2% vs -1.3%). OptimizeRx Corp produced more free cash flow last quarter ($7.1M vs $4.1M). Over the past eight quarters, OptimizeRx Corp's revenue compounded faster (28.0% CAGR vs -2.8%).

Cass Information Systems Inc is a leading provider of integrated financial automation and information management solutions for enterprises. Its core services cover freight payment processing, utility expense management, commercial payment services, and supporting data analytics tools, helping clients streamline financial workflows, cut operational costs, and gain clearer cross-category spending visibility to support smarter business decisions.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

CASS vs OPRX — Head-to-Head

Bigger by revenue
OPRX
OPRX
1.2× larger
OPRX
$32.2M
$26.2M
CASS
Growing faster (revenue YoY)
OPRX
OPRX
+1.1% gap
OPRX
-0.2%
-1.3%
CASS
Higher net margin
CASS
CASS
15.7% more per $
CASS
31.3%
15.6%
OPRX
More free cash flow
OPRX
OPRX
$2.9M more FCF
OPRX
$7.1M
$4.1M
CASS
Faster 2-yr revenue CAGR
OPRX
OPRX
Annualised
OPRX
28.0%
-2.8%
CASS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CASS
CASS
OPRX
OPRX
Revenue
$26.2M
$32.2M
Net Profit
$8.2M
$5.0M
Gross Margin
74.8%
Operating Margin
38.1%
26.6%
Net Margin
31.3%
15.6%
Revenue YoY
-1.3%
-0.2%
Net Profit YoY
78.3%
6535.9%
EPS (diluted)
$0.61
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CASS
CASS
OPRX
OPRX
Q4 25
$26.2M
$32.2M
Q3 25
$27.4M
$26.1M
Q2 25
$27.6M
$29.2M
Q1 25
$26.8M
$21.9M
Q4 24
$26.5M
$32.3M
Q3 24
$28.1M
$21.3M
Q2 24
$27.6M
$18.8M
Q1 24
$27.7M
$19.7M
Net Profit
CASS
CASS
OPRX
OPRX
Q4 25
$8.2M
$5.0M
Q3 25
$9.1M
$779.0K
Q2 25
$8.9M
$1.5M
Q1 25
$9.0M
$-2.2M
Q4 24
$4.6M
$-78.0K
Q3 24
$2.9M
$-9.1M
Q2 24
$4.5M
$-4.0M
Q1 24
$7.2M
$-6.9M
Gross Margin
CASS
CASS
OPRX
OPRX
Q4 25
74.8%
Q3 25
67.2%
Q2 25
63.8%
Q1 25
60.9%
Q4 24
68.1%
Q3 24
63.1%
Q2 24
62.2%
Q1 24
62.0%
Operating Margin
CASS
CASS
OPRX
OPRX
Q4 25
38.1%
26.6%
Q3 25
42.3%
7.9%
Q2 25
22.8%
10.9%
Q1 25
40.6%
-9.6%
Q4 24
19.7%
11.2%
Q3 24
13.4%
-40.2%
Q2 24
20.2%
-19.9%
Q1 24
32.1%
-25.5%
Net Margin
CASS
CASS
OPRX
OPRX
Q4 25
31.3%
15.6%
Q3 25
33.2%
3.0%
Q2 25
32.1%
5.2%
Q1 25
33.5%
-10.0%
Q4 24
17.3%
-0.2%
Q3 24
10.5%
-42.8%
Q2 24
16.2%
-21.3%
Q1 24
25.8%
-35.0%
EPS (diluted)
CASS
CASS
OPRX
OPRX
Q4 25
$0.61
$0.27
Q3 25
$0.68
$0.04
Q2 25
$0.66
$0.08
Q1 25
$0.66
$-0.12
Q4 24
$0.34
$0.00
Q3 24
$0.21
$-0.50
Q2 24
$0.32
$-0.22
Q1 24
$0.52
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CASS
CASS
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$758.4M
$23.4M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$243.0M
$128.3M
Total Assets
$2.6B
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CASS
CASS
OPRX
OPRX
Q4 25
$758.4M
$23.4M
Q3 25
$486.6M
$19.5M
Q2 25
$431.2M
$16.6M
Q1 25
$428.9M
$16.6M
Q4 24
$680.1M
$13.4M
Q3 24
$432.0M
$16.1M
Q2 24
$441.7M
Q1 24
$368.3M
Total Debt
CASS
CASS
OPRX
OPRX
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$36.8M
Q2 24
$37.3M
Q1 24
$37.8M
Stockholders' Equity
CASS
CASS
OPRX
OPRX
Q4 25
$243.0M
$128.3M
Q3 25
$243.4M
$122.3M
Q2 25
$240.8M
$119.3M
Q1 25
$234.2M
$116.3M
Q4 24
$229.0M
$117.0M
Q3 24
$237.6M
$114.5M
Q2 24
$229.9M
$121.0M
Q1 24
$229.5M
$122.5M
Total Assets
CASS
CASS
OPRX
OPRX
Q4 25
$2.6B
$176.9M
Q3 25
$2.5B
$170.3M
Q2 25
$2.3B
$169.3M
Q1 25
$2.3B
$167.8M
Q4 24
$2.4B
$171.2M
Q3 24
$2.3B
$165.2M
Q2 24
$2.3B
$172.9M
Q1 24
$2.3B
$176.4M
Debt / Equity
CASS
CASS
OPRX
OPRX
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.32×
Q2 24
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CASS
CASS
OPRX
OPRX
Operating Cash FlowLast quarter
$4.8M
$7.1M
Free Cash FlowOCF − Capex
$4.1M
$7.1M
FCF MarginFCF / Revenue
15.8%
22.0%
Capex IntensityCapex / Revenue
2.7%
0.0%
Cash ConversionOCF / Net Profit
0.59×
1.41×
TTM Free Cash FlowTrailing 4 quarters
$31.8M
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CASS
CASS
OPRX
OPRX
Q4 25
$4.8M
$7.1M
Q3 25
$12.3M
$3.2M
Q2 25
$-1.3M
$4.6M
Q1 25
$21.6M
$3.9M
Q4 24
$18.6M
$198.0K
Q3 24
$-198.0K
$1.8M
Q2 24
$10.7M
$782.0K
Q1 24
$9.8M
$2.1M
Free Cash Flow
CASS
CASS
OPRX
OPRX
Q4 25
$4.1M
$7.1M
Q3 25
$11.3M
$3.2M
Q2 25
$-2.6M
$4.6M
Q1 25
$19.0M
$3.8M
Q4 24
$18.4M
$181.0K
Q3 24
$-2.2M
$1.8M
Q2 24
$7.9M
$737.0K
Q1 24
$6.3M
$2.1M
FCF Margin
CASS
CASS
OPRX
OPRX
Q4 25
15.8%
22.0%
Q3 25
41.1%
12.2%
Q2 25
-9.5%
15.6%
Q1 25
71.0%
17.5%
Q4 24
69.5%
0.6%
Q3 24
-8.0%
8.3%
Q2 24
28.6%
3.9%
Q1 24
22.9%
10.6%
Capex Intensity
CASS
CASS
OPRX
OPRX
Q4 25
2.7%
0.0%
Q3 25
3.8%
0.0%
Q2 25
4.9%
0.0%
Q1 25
9.6%
0.1%
Q4 24
0.7%
0.1%
Q3 24
7.2%
0.1%
Q2 24
10.1%
0.2%
Q1 24
12.6%
0.2%
Cash Conversion
CASS
CASS
OPRX
OPRX
Q4 25
0.59×
1.41×
Q3 25
1.35×
4.11×
Q2 25
-0.15×
2.98×
Q1 25
2.41×
Q4 24
4.06×
Q3 24
-0.07×
Q2 24
2.38×
Q1 24
1.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CASS
CASS

Processing Fees$15.9M61%
Financial Fees$9.9M38%

OPRX
OPRX

Segment breakdown not available.

Related Comparisons